Target intelligence / Profile preview

Coagulation factor V (F5), Coagulation factor VIII (F8), Coagulation factor XI (F11), and Coagulation factor XIII (F13) (F5, F8, F11, F13)

Target
F5, F8, F11, F13
Molecular classification
Enzyme, Cofactor, Serine protease, Transglutaminase
01

Overview

Coagulation factors V, VIII, XI, and XIII are a specific group of proteins within the blood coagulation cascade that are primarily activated by thrombin (Factor IIa) to amplify and stabilize the formation of a blood clot [5, 6, 9]. Factors V (Proaccelerin) and VIII (Antihemophilic factor) function as essential non-enzymatic cofactors that dramatically accelerate the activation of prothrombin and factor X, respectively, facilitating a rapid burst of thrombin generation [1, 3, 10]. Factor XI (Plasma thromboplastin antecedent) is a serine protease that sustains this process through a feedback loop in the intrinsic pathway, while Factor XIII (Fibrin-stabilizing factor) is a transglutaminase that cross-links fibrin strands to provide mechanical stability and resistance to fibrinolysis [1, 13, 14, 17]. Deficiencies in these factors are associated with significant bleeding disorders, most notably Hemophilia A (Factor VIII deficiency) and Hemophilia C (Factor XI deficiency), which are managed through replacement therapies or bypass agents [1, 10]. Conversely, these factors—particularly Factor XI—have become major targets for next-generation anticoagulants, such as abelacimab and milvexian, which aim to prevent pathological thrombosis with a significantly lower risk of bleeding compared to traditional anticoagulants [2, 7, 13, 18]. The therapeutic landscape for these factors continues to evolve, with a focus on improving safety profiles and reducing the burden of treatment for patients with both hereditary deficiencies and thrombotic risks [7, 12, 15].

Other names
Coagulation factors V, VIII, XI, XIIIThrombin-activated coagulation factorsProaccelerinAntihemophilic factorPlasma thromboplastin antecedentFibrin-stabilizing factor
02

Mechanism of action

Replacement of deficient coagulation factors, inhibition of protease activity to prevent thrombus formation, and mimetic activity to substitute for missing cofactors.

03

Biological functions

Blood coagulationHemostasisFibrin stabilizationThrombin amplification
04

Disease associations

Hemophilia AHemophilia CFactor V deficiencyFactor XIII deficiencyThrombosisVenous thromboembolism
05

Safety considerations

Risk of major bleedingThrombotic eventsDevelopment of inhibitory antibodiesHypersensitivity reactions
06

Interacting drugs

Emicizumab

7 more in the full profile.

07

Biomarkers

Activated partial thromboplastin time (aPTT)Prothrombin time (PT)Factor activity levelsThrombin generation assay

Beyond the preview

Go deeper on Coagulation factor V (F5), Coagulation factor VIII (F8), Coagulation factor XI (F11), and Coagulation factor XIII (F13) (F5, F8, F11, F13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation factor V (F5), Coagulation factor VIII (F8), Coagulation factor XI (F11), and Coagulation factor XIII (F13) (F5, F8, F11, F13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call